A significantly longer time to treatment failure was demonstrated in the abacavir arm compared with the PI arm ( P = 0.03 ) while treatment failure was experienced by significantly more patients in the PI arm : 24 ( 23 % ) versus 12 ( 12 % ) ( P = 0.03 ) .
